Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
AbbVie
Astellas Pharma Inc
Amgen
Merck Sharp & Dohme LLC
AbbVie
Eli Lilly and Company
QuantumLeap Healthcare Collaborative
Revolution Medicines, Inc.
Gustave Roussy, Cancer Campus, Grand Paris
GlaxoSmithKline
Weill Medical College of Cornell University
Shandong Cancer Hospital and Institute
Oncology Center of Biochemical Education And Research
University of California, San Diego
The First Affiliated Hospital of Guangzhou Medical University
Nanfang Hospital, Southern Medical University